Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00309335 · ClinicalTrials.gov registry record · Phase 3
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures
A Phase 3 study of Anesthesia, Dental, sponsored by Novalar Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT00309335 is a Phase 3 study of Anesthesia, Dental that has completed, run by Novalar Pharmaceuticals. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00309335, a Phase 3 study of Anesthesia, Dental, has completed, sponsored by Novalar Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This Phase 3 clinical study is designed as a multicenter, randomized, blinded, controlled study to evaluate the efficacy, pharmacodynamics, and safety of NV-101 administered as a submucosal injection following completion of a restorative or periodontal maintenance procedure requiring local anesthesia with an agent containing a vasoconstrictor. Local vasodilatation that results in more rapid clearance of the anesthetic is the proposed mechanism of action.
Conditions Studied
Interventions
- DRUG Phentolamine Mesylate (NV-101)
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00309335
The ClinicalTrials.gov registry entry for NCT00309335 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novalar Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anesthesia, Dental appearing as the primary indexed condition, and to 1 intervention - of which Phentolamine Mesylate (NV-101) is the first listed.
NCT00309335 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00309335 about?
NCT00309335 is a clinical study titled "Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures". This Phase 3 clinical study is designed as a multicenter, randomized, blinded, controlled study to evaluate the efficacy, pharmacodynamics, and safety of NV-101 administered as a submucosal injection following completion of a restorative or periodontal maintenance procedure requiring local anesthesi...
What is the current status of trial NCT00309335?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2006-02. Estimated completion is 2006-07.
What conditions does trial NCT00309335 study?
This clinical trial studies the following conditions: Anesthesia, Dental.
What interventions are being tested in trial NCT00309335?
The interventions under investigation include: Phentolamine Mesylate (NV-101) (DRUG).
Who is sponsoring clinical trial NCT00309335?
This trial is sponsored by Novalar Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00309335 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Dental
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.